No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
OEC Orion SA
- 23.250
- +0.450+1.97%
Close Jul 22 16:00 ET
1.36BMarket Cap15.71P/E (TTM)
23.260High22.600Low329.05KVolume22.930Open22.800Pre Close7.61MTurnover0.58%Turnover Ratio13.44P/E (Static)58.31MShares28.40152wk High2.83P/B1.32BFloat Cap19.25152wk Low0.08Dividend TTM56.92MShs Float34.010Historical High0.36%Div YieldTTM2.90%Amplitude5.842Historical Low23.122Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Orion Innovation Nombra a Cyrus Lam Como Director Financiero
Orion (NYSE:OEC) Will Want To Turn Around Its Return Trends
Orion S.A. Announces Second Quarter 2024 Earnings Release Date and Conference Call Information
Is Now The Time To Look At Buying Orion S.A. (NYSE:OEC)?
Is Orion S.A. (NYSE:OEC) Expensive For A Reason? A Look At Its Intrinsic Value
Moody's Affirms Orion Ratings on Market Position, Operating Profitability
Comments
Orion is undervalued compared to peers, with high volatility presenting buying opportunities. Optimistic future earnings could boost cash flows and share value, but financial health is also crucial.
Is Orion S.A. (NYSE:OEC) Potentially Undervalued? 1
Gainers:
• $Revlon(REV.US$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $United States Steel(X.US$ +6.4% (issues upside EPS guidance),
• $Ellington Financial(EFC.US$ +5% (reports book value per share)
• $Aurora Mobile(JG.US$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $Citi Trends(CTRN.US$ +4.4% (names new CFO)
• $Roku Inc(ROKU.US$ +4.2% (ROKU an...
• $Revlon(REV.US$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $United States Steel(X.US$ +6.4% (issues upside EPS guidance),
• $Ellington Financial(EFC.US$ +5% (reports book value per share)
• $Aurora Mobile(JG.US$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $Citi Trends(CTRN.US$ +4.4% (names new CFO)
• $Roku Inc(ROKU.US$ +4.2% (ROKU an...
12
Gainers:
• $Clovis Oncology(CLVS.US$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience(DARE.US$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology(KULR.US$ +9.5% (secured a battery sa...
• $Clovis Oncology(CLVS.US$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience(DARE.US$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology(KULR.US$ +9.5% (secured a battery sa...
14
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg